论文部分内容阅读
作者首次报告肌层浸润性尿路上皮癌(UCB)行根治性全膀胱切除(RC)术后2、3年无疾病生存率(DFS2、DFS3)与5年总生存率(OS5)之间的关系。德国10家泌尿外科中心协作,收集1989年至2008年欧洲8家中心UCB行RC患者2 483例,前期研究中纳入研究者为pT2~4a及软组织切缘(STSM)阴性患者1 738例,前期被排除者为切缘阳性或其他分期(pT0~T1、pT4b)患者745例。通过Kappa统计检验DFS2或DFS3和OS5的一致性。结果:DFS2与OS5总的一致性为86.5%(排除组
The authors report for the first time between 2 and 3 year disease free survival (DFS2, DFS3) and 5 year overall survival (OS5) after radical cystectomy (RC) of mycotic invasive carcinoma of the urinary tract (UCB) relationship. Ten urology centers in Germany collaborated to collect 2 483 RC patients from eight centers in eight European centers from 1989 to 2008. The previous study included 1738 patients with pT2-4a and soft tissue resection margin (STSM) negative, Patients who were excluded were positive margins or other staging (pT0-T1, pT4b) of 745 patients. The consistency of DFS2 or DFS3 and OS5 was tested by Kappa statistics. Results: The overall consistency of DFS2 with OS5 was 86.5% (Excluding group